Market pulse › Dr Lal PathLabs
Dr Lal PathLabs
Today0 stories · 0 articles
Net tone–
Market check₹1,952.30 −0.46%
Developing0 storylines
224 Sept
525 Sept
126 Sept
027 Sept
028 Sept
Deal▲ bullishDr Lal PathLabs’ arm acquires 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs’ arm acquired an 80% stake in Ghana’s Sunshine HealthcareGhanaPharma and healthcareHospitals
Broker call▲ bullishBroker call recommends Dr Lal PathLabs with a ₹2,100 targetEmkay Global Financial ServicesStockbrokers
Market move● mixedStocks to watch, Sept 25: PB Fintech, SAIL, Sedemac Mechatronics, Dr Lal Pathlabs, Genesys International, Wheels IndiaPB FintechSAILSEDEMAC Mechatronics
Market move● mixedStocks to watch today, September 25: Tata Group, Lemon Tree Hotels, PB Fintech, JSW Cement and moreTata Group stocks, Lemon Tree Hotels, Dr Lal PathLabs, PB Fintech, JSW Cement and KPIL are in focusLemon Tree HotelsPB FintechJSW Cement
Market move▼ bearishStocks in news: Waaree Energies, PB Fintech, Lemon Tree Hotels and Dr Lal PathLabsNifty 50 fell by over 380 pointsPB FintechNifty and SensexFintech and payments
Market move● mixedStocks to Watch Today: ESDS Software, Purple Style Labs, Axiom Gas, Dr Lal PathLabs, LCC Projects, Waaree...Waaree EnergiesPurple Style LabsESDS Software Solution
Market move● mixedStocks to Watch for September 25: PB Fintech, Inox Green Energy, Dr Lal Path, JSW Cement and moreWaaree Clean Energy Solutions is entering India’s specialty gases businessSN GenelabWaaree EnergiesPB Fintech
Deal▲ bullishDr Lal PathLabs to buy 70% of SN Genelab; reports differ on deal valueDr Lal PathLabs will acquire a **70% stake** in SN GenelabHospitalsSN Genelab